Chapter

Institutional pathways for integrating genetic testing into mainstream health care

Hristina Petkova

in The Economics of New Health Technologies

Published in print May 2009 | ISBN: 9780199550685
Published online February 2010 | e-ISBN: 9780191720543 | DOI: http://dx.doi.org/10.1093/acprof:oso/9780199550685.003.0017
 Institutional pathways for integrating genetic testing into mainstream health care

More Like This

Show all results sharing this subject:

  • Public Health and Epidemiology

GO

Show Summary Details

Preview

This chapter considers how new knowledge generated by advances in science can be assimilated into public health care systems, allowing quicker integration of new technology into routine care. An example is drawn from maturity-onset diabetes of the young (MODY) study applied to two very different health care systems: Germany and the UK. The chapter shows that differences in the organization, funding, and delivery of care generally can affect genetic innovation. The degree of institutional take-up of testing for MODY as a single gene disorder with highly differential diagnosis and established clinical implications for alternative treatment shows strong association with the general pattern of the health care structures. The implementation trajectories for MODY diagnosis in the two countries diverge at several points, from research expertise and pattern of provision, to diffusion channels in mainstream service.

Keywords: medical innovation; public health; MODY; Germany; UK

Chapter.  7539 words. 

Subjects: Public Health and Epidemiology

Full text: subscription required

How to subscribe Recommend to my Librarian

Buy this work at Oxford University Press »

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.